For research use only
| Cat No. | ABC-X0356C |
| Product Type | Overexpression Stable Cell Lines |
| Cell Type | Epithelial |
| Species | Rat |
| Host Cell | CHOK1 |
| Source Organ | Ovary |
| Disease | Normal |
| Storage | Liquid Nitrogen |
Stable CHOK1 cell line expressing rat LAG3, ideal for immune checkpoint signaling, T cell exhaustion, and translational research in immunotherapy models.
LAG3 CHOK1 Overexpression Cell Line is a genetically engineered model derived from selected Chinese hamster ovary (CHOK1) parental cell line based on customers’ requirement. LAG3 CHOK1 overexpression cell line is generated by stable integration of exogenous rat LAG3 into CHOK1 host cells using our optimized transduction of lentiviral vectors. Overexpression clone is validated at gene level by qRT-PCR.
Target
The LAG3 gene encodes a transmembrane protein expressed on activated T cells and natural killer cells, functioning as an immune checkpoint regulator. It negatively regulates T cell activation and proliferation and plays a key role in maintaining immune tolerance. LAG3 is a promising immunotherapeutic target in cancer and chronic infections due to its suppressive effects on antitumor immune responses. AcceGen offers generation of stable overexpression cell lines targeting any gene of your interest. Polyclonal or monoclonal is optional based on customers’ research needs.
| Species | Rat |
| Cat.No | ABC-X0356C |
| Product Category | Transfected Stable Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Epithelial |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 °C, 5% CO2 |
| Source Organ | Ovary |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Overexpression Stable Cell Lines |
| Host Cell | CHOK1 |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
The LAG3 CHOK1 Overexpression Cell Line serves as a powerful tool to investigate LAG3-mediated immunosuppression and checkpoint blockade strategies. This model enables mechanistic studies of T cell exhaustion and immune modulation in tumor and inflammatory microenvironments. It is utilized for high-throughput screening of LAG3-targeted therapeutics, including monoclonal antibodies and fusion proteins.